Clinical Trials Browser

Phase 1 × Multiple Myeloma × Ascorbic Acid × Clear all

NCT00590603 2014-01-08

AAV

Phase 1 Terminated

Multiple Myeloma

NCT00258245 2013-04-29

Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia

Phase 1 Completed

Multiple Myeloma, Neoplasms, Plasma Cell